Literature DB >> 21127184

Off-the-shelf T-cell therapy.

Laurence J N Cooper1.   

Abstract

Year:  2010        PMID： 21127184     DOI： 10.1182/blood-2010-10-308379

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

1.  A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR.

Authors:  Hiroki Torikai; Andreas Reik; Pei-Qi Liu; Yuanyue Zhou; Ling Zhang; Sourindra Maiti; Helen Huls; Jeffrey C Miller; Partow Kebriaei; Brian Rabinovich; Brian Rabinovitch; Dean A Lee; Richard E Champlin; Chiara Bonini; Luigi Naldini; Edward J Rebar; Philip D Gregory; Michael C Holmes; Laurence J N Cooper
Journal:  Blood       Date:  2012-04-24       Impact factor: 22.113

Review 2.  Challenges and opportunities of allogeneic donor-derived CAR T cells.

Authors:  Yinmeng Yang; Elad Jacoby; Terry J Fry
Journal:  Curr Opin Hematol       Date:  2015-11       Impact factor: 3.284

3.  How an alloreactive T-cell receptor achieves peptide and MHC specificity.

Authors:  Yuan Wang; Nishant K Singh; Timothy T Spear; Lance M Hellman; Kurt H Piepenbrink; Rachel H McMahan; Hugo R Rosen; Craig W Vander Kooi; Michael I Nishimura; Brian M Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-01       Impact factor: 11.205

4.  Alloreactive cytotoxic T cells provide means to decipher the immunopeptidome and reveal a plethora of tumor-associated self-epitopes.

Authors:  Shraddha Kumari; Sébastien Wälchli; Lars-Egil Fallang; Weiwen Yang; Fridtjof Lund-Johansen; Ton N Schumacher; Johanna Olweus
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-16       Impact factor: 11.205

Review 5.  Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells.

Authors:  Michelle L Saetersmoen; Quirin Hammer; Bahram Valamehr; Dan S Kaufman; Karl-Johan Malmberg
Journal:  Semin Immunopathol       Date:  2018-10-25       Impact factor: 9.623

6.  Protein L: a novel reagent for the detection of chimeric antigen receptor (CAR) expression by flow cytometry.

Authors:  Zhili Zheng; Nachimuthu Chinnasamy; Richard A Morgan
Journal:  J Transl Med       Date:  2012-02-13       Impact factor: 5.531

7.  'Off-the-shelf' allogeneic antigen-specific adoptive T-cell therapy for the treatment of multiple EBV-associated malignancies.

Authors:  Debottam Sinha; Sriganesh Srihari; Kirrliee Beckett; Laetitia Le Texier; Matthew Solomon; Archana Panikkar; George R Ambalathingal; Lea Lekieffre; Pauline Crooks; Sweera Rehan; Michelle A Neller; Corey Smith; Rajiv Khanna
Journal:  J Immunother Cancer       Date:  2021-02       Impact factor: 13.751
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.